biomarker validation
Cofactor Quickly Moving Immunotherapy Predictive Test to Market With Data From Intermountain Spinout
Premium
Culmination Bio's 4.5 million biospecimens and longitudinal omics and clinical data may help Cofactor rapidly advance the OncoPrism assay into multiple cancer types.
OncoHost Raises $35M in Series C Financing
The Israeli firm will use the funds to expand its PROPHETIC trial and support the US commercial launch of the Prophet platform.
MD Anderson, BostonGene Ink Collaboration to Develop Cancer Diagnostics
The partners will validate therapeutically actionable cancer biomarker targets and develop multiple tests from this research.
Researchers Find Keratin 17 Biomarker Shows Promise as Diagnostic Indicator for Bladder Cancer
Premium
The biomarker can detect both aggressive and low-grade forms of bladder cancer, and a test for the biomarker has been licensed by KDx Diagnostics.
Valted Seq Lands Exclusive Rights to Evaluate Johns Hopkins Neurodegenerative Disease Dx Assays
The biomarker assays could one day be used as companion diagnostics for new treatments of Parkinson's and related diseases.
Feb 12, 2020
Nov 19, 2019
Oct 30, 2019
Feb 2, 2018